• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

antivirals

Crying baby with measles
Research

As measles surges, the first treatment remains a pipe dream

Measles drug development is fraught with challenges, and there are no approved drugs for the disease or any being tested in clinical trials.
Darren Incorvaia Jul 17, 2025 2:02pm
The spike protein on the SARS-CoV-2 virus up close

Protease inhibitor outperforms Paxlovid protecting lungs of mice

Mar 14, 2024 6:30am
A graphic of a persons outstretched hand with virus particles surrounding it

COVID-19 Moonshot pioneers explain success of open innovation

Nov 27, 2023 10:00am
GlaxoSmithKline building

GSK gives early look at HIV bNAb's power

Oct 25, 2022 10:00am
Cytomegalovirus CMV herpes herpesvirus virus

New antiviral class could halt treatment-resistant viruses

May 16, 2022 3:10pm
AbbVie

AbbVie, Scripps prep for endemic COVID-19 with antiviral collab

Mar 15, 2022 11:29am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings